Opening book details…
Can I read Strategies for Prevention and Management of Ocular Events Occurring with Mirvetuximab Soravtansine on EtoBox?
Strategies for Prevention and Management of Ocular Events Occurring with Mirvetuximab Soravtansine by Andrew Hendershot; Mark Slabaugh; Kamran M. Riaz; Kathleen N. Moore; David M. O'Malley; Ursula Matulonis; Gottfried E. Konecny is a Medicine article available to read on EtoBox.
What is Strategies for Prevention and Management of Ocular Events Occurring with Mirvetuximab Soravtansine about?
Mirvetuximab soravtansine (MIRV) is a first-in-class antibody-drug conjugate (ADC) targeting folate receptor alpha (FRα) and is indicated for the treatment of adult patients with FRα-positive, platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer who have received 1 to 3 prior systemic treatment regimens. MIRV has demonstrated single-agent anticancer activity in clinical trials, with a differentiated safety profile comprising primarily low-grade, resolvable gastrointestinal and ocular adverse events (AEs). Pooled safety analysis of 464 MIRV-treated patients across 3 trials, including the phase 2 SORAYA study, found that 50% of patients had ≥1 ocular AEs of interest (AEIs) of blurred vision or keratopathy, the majority being grade ≤2. Grade 3 ocular AEIs occurred in 5% of patients, and 1 patient (0.2%) had a grade 4 event of keratopathy. All grade ≥2 AEIs of blurred vision and keratopathy resolved to grade 1 or 0 in patients with complete follow-up data. MIRV-associated ocular AEs were primarily characterized by resolvable changes to the corneal epithelium, with no cases of corneal ulcers or perforations. This reflects the distinctive, milder ocular saf
Who reads Strategies for Prevention and Management of Ocular Events Occurring with Mirvetuximab Soravtansine?
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Andrew Hendershot; Mark Slabaugh; Kamran M. Riaz; Kathleen N. Moore; David M. O'Malley; Ursula Matulonis; Gottfried E. Konecny
- Publisher
- Elsevier BV
- Published
- 2023
- Language
- EN
- Field
- Medicine (Health Sciences)